Cite

    Zhang, J. et al. (n.d.). The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study. Journal of dermatological science. 88 (1), pp. 36-45. [Online].